Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy.

Biotechnology

Cellectis

The Raleigh office focuses on quality assurance, documentation, and site coordination for manufacturing and validation processes.

Raleigh

The New York office focuses on leadership in gene editing research, clinical trials, and strategic financial management.

New York

This department focuses on research and development of innovative processes to enhance production efficiency and product quality.

Process Development

This department focuses on ensuring the quality and reliability of products through systematic testing and compliance processes.

Quality Assurance

The Clinical Advisors at Cellectis play a crucial role in guiding the development and implementation of innovative cancer immunotherapy treatments. They provide expert insights on clinical strategies, regulatory requirements, and patient safety, ensuring that clinical trials align with best practices and advance the company's therapeutic objectives. Through their collaboration with research and development teams, they help translate scientific discoveries into effective therapies for patients.

Clinical Advisors

This department focuses on conducting studies, experiments, and analysis to contribute to knowledge and innovation.

Research Department

This department focuses on the research and development of clinical strategies and management for pharmaceuticals and treatments.

Clinical Sciences

This department focuses on innovating and developing new processes and products.

People (5)

Jobs (0)

Other teams

Quality Assurance

Clinical Advisors

Research Department

Clinical Sciences

Research and Development